Skip to main content
. 2017 Nov 11;8(62):105727–105734. doi: 10.18632/oncotarget.22394

Figure 1. The effect of RXDX-106 in gastric cancer cell lines.

Figure 1

(A) Basal protein expression level of p-MerTK and MerTK, the target of RXDX-106, in gastric cancer cell lines. (B) Results of cell viability under 1μM RXDX-106 treatment. Statistical significance was calculated using paired t-test and is indicated with *** for p-value < 0.0001. (C, D) Molecular change of proliferative signaling molecules and RXDX-106 targeted molecules. For Western blotting, cells were exposed to 1μM RXDX-106 for 3 days or indicated time.